Bioorganic Chemistry · 2019 · 80 citations · 51 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryStructure-activity RelationshipsDe Novo Drug DesignLead Compound DesignLigand BindingLigand-based DesignMacrocyclic Drug DesignMolecular DockingMacrocyclic Scaffold DesignP53 InactivationSpirocyclic Scaffold DiversificationSpirocyclic ScaffoldsSpiroheterocycle SynthesisSpirooxazine CompoundsSpiropyran Compounds
51
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Katsunori Nakano, Karen H. Vousden · Molecular Cell · 2001 · 2.3K citations · Full text
The p53-mdm-2 autoregulatory feedback loop.
J. Henri Bayle, David C. Olson, Arnold J. Levine · Genes & Development · 1993 · 1.8K citations · Full text
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Suzanne J. Baker, Sanford D. Markowitz, Eric R. Fearon et al. · Science · 1990 · 1.8K citations